Internal Medicine, Gastroenterology · Jacksonville, FL
NPI
1831183938
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
2 Shircliff Way Ste 435
Jacksonville, FL, 32204
Phone (904) 388-8686
Groups this clinician bills Medicare through
Medicare paid, 2024
$334K
3,409 services
Medicare patients, 2024
850
Average age 73
Drug cost, 2024
$2.4M
3,559 prescriptions
Company payments, 2025
$1,177
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdi Abbassi was code 99232 (hospital e&m - subsequent), 1,094 times for 83 patients. In total Abdi Abbassi billed 3,409 services in 32 codes, and Medicare paid $334K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,094 | 83 | $66.29 | $73K |
| 99214 Office E&M - Established | Office | 578 | 388 | $100.99 | $58K |
| 45380 Lower GI Endoscopy - Other | Facility | 349 | 348 | $138.81 | $48K |
| 99204 Office E&M - New | Office | 347 | 346 | $122.85 | $43K |
| 43239 Upper GI Endoscopy | Facility | 330 | 324 | $78.86 | $26K |
| 99213 Office E&M - Established | Office | 247 | 230 | $73.85 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 149 | 76 | $99.46 | $15K |
| 45385 Colonoscopy - Lesion Removal | Facility | 108 | 107 | $216.81 | $23K |
| 99223 Hospital E&M - Initial | Facility | 79 | 78 | $143.75 | $11K |
| 43450 Digestive/Gastrointestinal | Facility | 22 | 22 | $34.46 | $758 |
| 43246 Upper GI Endoscopy | Facility | 20 | 18 | $162.60 | $3,252 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 16 | 16 | $185.99 | $2,976 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 12 | 12 | $183.43 | $2,201 |
By year: 2022 $314K for 3,313 services; 2023 $330K for 3,763 services; 2024 $334K for 3,409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abdi Abbassi prescribed most often to Medicare patients was Omeprazole, with 1,442 prescriptions and refills. In total Abdi Abbassi wrote 3,559 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 1,442 | 2,696 | 698 | $16K |
| Pantoprazole Sodium Generic | 354 | 881 | 158 | $3,083 |
| Amoxicillin Generic | 214 | 214 | 210 | $1,415 |
| Clarithromycin Generic | 156 | 156 | 155 | $4,676 |
| Famotidine Generic | 142 | 321 | 65 | $1,541 |
| Linzess Linaclotide | 135 | 201 | 56 | $109K |
| Dicyclomine Hcl Generic | 90 | 121 | 46 | $2,086 |
| Ondansetron Odt Ondansetron | 86 | 87 | 52 | $1,980 |
| Rifabutin Generic | 59 | 59 | 59 | $15K |
| Sucralfate Generic | 50 | 53 | 38 | $5,380 |
| Esomeprazole Magnesium Generic | 43 | 99 | 17 | $1,570 |
| Spironolactone Generic | 42 | 110 | 15 | $665 |
| Creon Lipase/Protease/Amylase | 40 | 54 | 14 | $163K |
| Furosemide Generic | 39 | 101 | 16 | $173 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 36 | 36 | 33 | $2,266 |
Brand drugs: 479 claims; generic drugs: 3,080 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdi Abbassi $1,177 ($1,177 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $416.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $416 |
| Janssen Biotech, Inc. JNJ | 13 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $169 |
| Ardelyx, Inc. ARDX | 6 | $119 |
| Lilly USA, LLC LLY | 4 | $89.53 |
| Pfizer Inc. PFE | 3 | $61.84 |
| Aimmune Therapeutics, Inc. | 3 | $51.16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $22.52 |
| Amgen Inc. AMGN | 1 | $15.66 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $9.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.